Literature DB >> 33068033

L-glutamine use in adults with sickle cell disease: Clinical trials where success meets reality.

Ugochi O Ogu1,2, Merin Thomas1, Florence Chan3,4, Leena Vattappally1, Gracy Sebastian1, Andrew Crouch1, Shuo You1, Caterina P Minniti1.   

Abstract

Entities:  

Year:  2020        PMID： 33068033     DOI： 10.1002/ajh.26021

Source DB:  PubMed          Journal:  Am J Hematol        ISSN： 0361-8609            Impact factor:   10.047


× No keyword cloud information.
  3 in total

1.  Pediatric Patients With Sickle Cell Disease at a Public Hospital: Nutrition, Compliance and Early Experience With L-Glutamine Therapy.

Authors:  Moran Gotesman; Guy Elgar; Laura Hernandez Santiago; Abigail Alvarez; Youngju Pak; Henry J Lin; Joseph L Lasky; Eduard H Panosyan
Journal:  In Vivo       Date:  2022 Jul-Aug       Impact factor: 2.406

Review 2.  L-glutamine for sickle cell disease: more than reducing redox.

Authors:  Firas Jafri; Gyuhee Seong; Tim Jang; Emanuela Cimpeanu; Maria Poplawska; Dibyendu Dutta; Seah H Lim
Journal:  Ann Hematol       Date:  2022-05-14       Impact factor: 4.030

Review 3.  Sickle cell vaso-occlusion: The dialectic between red cells and white cells.

Authors:  Nicola Conran; Stephen H Embury
Journal:  Exp Biol Med (Maywood)       Date:  2021-04-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.